3D Molecular Sciences Presents its New Patented 3D Encoded Particle Array Tool for Multiplexing Bioassays at BioArray Europe
3D Molecular Sciences presented a poster providing new assay data on the Company’s multiplexing enabling platform technology for molecular medicine at the BioArray Europe conference, taking place in Cambridge, UK, on 1 October 2002. The new patented assay system consists of microfabricated encoded particles of a variety of designs, attachment chemistries and a choice of readers to interpret the results.
The poster presentation, entitled Several Assay Systems Presented Using a New Patented 3D Encoded Particle Array Tool for Multiplexing Bioassays, shows new data demonstrating the compatibility of the Company’s individually coded particles with a diverse range of assays including nucleic acids and cytokines. The Company’s technology platform offers an inexpensive and flexible tool to the pharmaceutical, biotech and clinical diagnostic industries that allows for a superior volume of tests, a scaleable capability and multiplexing of samples. It has the potential to screen for gene-linked diseases such as cancer, Alzheimer`s, obesity and cystic fibrosis. It can also offer great possibilities in compound library screening, environmental monitoring and in anti-terrorism systems.
Dr Elizabeth Hill, 3D Molecular Sciences’ CEO, said, “Our 3DMS™ 3D particle array tools are designed to carry out large-scale bioassay analysis required in drug discovery, drug development and in diagnostics in a low cost and fast manner. Our data presented at this conference clearly illustrates the capability this platform has, and we will continue to maintain our technology programme so we can exploit this platform to the full.”
The Company’s 3DMS™ particle array system is a new, patented assay and detection technology that uses individually microscopic encoded particles for the detection of biological content or biochemical interactions in a wide variety of analytical bioassays and test formats. Such formats are for proteomics, immunoassays gene expression and SNP analysis.
Work is currently underway on a number of further commercial assay systems to illustrate the 3DMS 3D-particle array capability. The Company has a strong patent position and welcomes the opportunity to discuss licensing and collaboration with commercial partners to build and develop this platform further with suitable commercial assay applications.
Caroline Stupnicka | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...